Cargando…

Clinical implications of prospective genomic profiling of metastatic breast cancer patients

BACKGROUND: Metastatic breast cancer remains incurable. Next-generation sequencing (NGS) offers the ability to identify actionable genomic alterations in tumours which may then be matched with targeted therapies, but the implementation and utility of this approach is not well defined for patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Geelen, Courtney T., Savas, Peter, Teo, Zhi Ling, Luen, Stephen J., Weng, Chen-Fang, Ko, Yi-An, Kuykhoven, Keilly S., Caramia, Franco, Salgado, Roberto, Francis, Prudence A., Dawson, Sarah-Jane, Fox, Stephen B., Fellowes, Andrew, Loi, Sherene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436992/ https://www.ncbi.nlm.nih.gov/pubmed/32811538 http://dx.doi.org/10.1186/s13058-020-01328-0

Ejemplares similares

Correction to: Clinical implications of prospective genomic profiling of metastatic breast cancer patients
por: van Geelen, Courtney T., et al.
Publicado: (2022)

Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study
por: Zivanovic Bujak, Andjelija, et al.
Publicado: (2020)

The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program “CASCADE”
por: Savas, Peter, et al.
Publicado: (2016)

Correction: The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE"
por: Savas, Peter, et al.
Publicado: (2017)

Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer
por: Teo, Zhi Ling, et al.
Publicado: (2023)

Checkpoint blockade in the treatment of breast cancer: current status and future directions
por: Wein, Lironne, et al.
Publicado: (2018)

Clinical Validity and Utility of Tumor-Infiltrating Lymphocytes in Routine Clinical Practice for Breast Cancer Patients: Current and Future Directions
por: Wein, Lironne, et al.
Publicado: (2017)

Residual disease and immune infiltration as a new surrogate endpoint for TNBC post neoadjuvant chemotherapy
por: Luen, Stephen L., et al.
Publicado: (2019)

Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer
por: Dushyanthen, Sathana, et al.
Publicado: (2017)

Combining Radiotherapy and Immunotherapy in Metastatic Breast Cancer: Current Status and Future Directions
por: David, Steven, et al.
Publicado: (2022)

Deciphering clonality in aneuploid breast tumors using SNP array and sequencing data
por: Lönnstedt, Ingrid M, et al.
Publicado: (2014)

Relevance of tumor-infiltrating lymphocytes in breast cancer
por: Dushyanthen, Sathana, et al.
Publicado: (2015)

Understanding the barriers to, and facilitators of, ovarian toxicity assessment in breast cancer clinical trials
por: Cui, Wanyuan, et al.
Publicado: (2022)

Tumor-infiltrating lymphocytes, breast cancer subtypes and therapeutic efficacy
por: Loi, Sherene
Publicado: (2013)

Stereotactic ablative body radiotherapy (SABR) for bone only oligometastatic breast cancer: A prospective clinical trial
por: David, Steven, et al.
Publicado: (2019)

Triple-negative breast cancer: recent treatment advances
por: Bergin, Alice R T, et al.
Publicado: (2019)

Immune checkpoint inhibition in the treatment of early stage triple negative breast cancer: 2021 update()
por: Brown, Lauren C., et al.
Publicado: (2021)

Immunotherapy in Early-Stage Triple-Negative Breast Cancer: Where Are We Now and Where Are We Headed?
por: Dixon-Douglas, Julia, et al.
Publicado: (2023)

Infiltrating immune cells in benign breast disease and risk of subsequent invasive breast cancer
por: Rohan, Thomas E., et al.
Publicado: (2021)

PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data
por: Zardavas, Dimitrios, et al.
Publicado: (2014)

Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection
por: Criscitiello, Carmen, et al.
Publicado: (2010)

Prediction of breast cancer prognosis using gene set statistics provides signature stability and biological context
por: Abraham, Gad, et al.
Publicado: (2010)

Canary: an atomic pipeline for clinical amplicon assays
por: Doig, Kenneth D., et al.
Publicado: (2017)

Findings from precision oncology in the clinic: rare, novel variants are a significant contributor to scaling molecular diagnostics
por: Doig, Kenneth D., et al.
Publicado: (2022)

Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)
por: Tovey, Holly, et al.
Publicado: (2023)

Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer
por: Loi, Sherene, et al.
Publicado: (2022)

Symptom modelling can be influenced by psychiatric categories: choices for research domain criteria (RDoC)
por: Fellowes, Sam
Publicado: (2017)

How autism shows that symptoms, like psychiatric diagnoses, are 'constructed': methodological and epistemic consequences
por: Fellowes, Sam
Publicado: (2021)

Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor–Positive Metastatic Breast Cancer
por: Turner, Nicholas C., et al.
Publicado: (2019)

Feasibility of developing reliable gene expression modules from FFPE derived RNA profiled on Affymetrix arrays
por: Jose, Vinu, et al.
Publicado: (2018)

Exercise as a diagnostic and therapeutic tool for preventing cardiovascular morbidity in breast cancer patients– the BReast cancer EXercise InTervention (BREXIT) trial protocol
por: Foulkes, Stephen J., et al.
Publicado: (2020)

Multiplexed transcriptome analysis to detect ALK, ROS1 and RET rearrangements in lung cancer
por: Rogers, Toni-Maree, et al.
Publicado: (2017)

Tumour-infiltrating lymphocytes in non-invasive breast cancer: A systematic review and meta-analysis
por: Caparica, Rafael, et al.
Publicado: (2021)

Immune molecular profiling of a multiresistant primary prostate cancer with a neuroendocrine-like phenotype: a case report
por: Williams, Scott G., et al.
Publicado: (2020)

Establishing the Link between X-Chromosome Aberrations and TP53 Status, with Breast Cancer Patient Outcomes
por: Caramia, Franco, et al.
Publicado: (2023)

Tumor P70S6K hyperactivation is inversely associated with tumor-infiltrating lymphocytes in triple-negative breast cancer
por: Jimeno, Rebeca, et al.
Publicado: (2022)

EFFECT OF DEHYDROASCORBIC ACID ON THE ISLETS OF LANGERHANS OF THE RAT PANCREAS
por: Merlini, Dino, et al.
Publicado: (1965)

Consumption of Eggs Alone or Enriched with Annatto (Bixa orellana L.) Does Not Increase Cardiovascular Risk in Healthy Adults—A Randomized Clinical Trial, the Eggant Study
por: Galvis, Yeisson, et al.
Publicado: (2023)

William Byrd
por: Fellowes, Edmund Horace, 1870-1951
Publicado: (1948)

Simulating chalcogen bonding using molecular mechanics: a pseudoatom approach to model ebselen
por: Fellowes, Thomas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7v40di1kg0k5mgre692o9tooc8